The role of immune and metabolic biomarkers for improved management of sepsis patients

References

• Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39(2):165;228
   Google Scholar
• Schuetz P, Christ-Crain M, Muller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections – hope for hype? Swiss Med Wkly 2009;139(23-24):318-26
   PubMed Web of Science ®Google Scholar
• Schutz P, Bally M, Stanga Z, Keller U. Loss of appetite in acutely ill medical inpatients: physiological response or therapeutic target? Swiss Med Wkly 2014;144:w13957
   Google Scholar
• Schuetz P, Wolbers M, Christ-Crain M, et al. Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections. Crit Care 2010;14(3):R106
   PubMed Web of Science ®Google Scholar
• Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 2010;14(1):R15
   PubMed Web of Science ®Google Scholar
• Mitsuma SF, Mansour MK, Dekker JP, et al. Promising new assays and technologies for the diagnosis and management of infectious diseases. Clin Infect Dis 2013;56(7):996-1002
   PubMed Web of Science ®Google Scholar
• Skibsted S, Jones AE, Puskarich MA, et al. Biomarkers of endothelial cell activation in early sepsis. Shock 2013;39(5):427-32
   PubMed Web of Science ®Google Scholar
• Vincent JL. Dear SIRS, I’m sorry to say that I don’t like you. Crit Care Med 1997;25(2):372-4
   PubMed Web of Science ®Google Scholar
• Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013;13(5):426-35
   PubMed Web of Science ®Google Scholar
• Schuetz P, Suter-Widmer I, Chaudri A, Procalcitonin-Guided Antibiotic T, Hospitalisation in Patients with Lower Respiratory Tract Infections Study G. Prognostic value of procalcitonin in community-acquired pneumonia. Eur Respir J 2011;37(2):384-92
   PubMed Web of Science ®Google Scholar
• Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 2011;9:107
   PubMed Web of Science ®Google Scholar
• Haeuptle J, Zaborsky R, Fiumefreddo R, et al. Prognostic value of procalcitonin in Legionella pneumonia. Eur J Clin Microbiol 2009;28(1):55-60
   Google Scholar
• Rivers E, Nguyen B, Havstad S, Early Goal-Directed Therapy Collaborative G. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345(19):1368-77
   PubMed Web of Science ®Google Scholar
• Kumar A, Haery C, Paladugu B, et al. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels. J Infect Dis 2006;193(2):251-8
   PubMed Web of Science ®Google Scholar
• Puskarich MA, Trzeciak S, Shapiro NI, Emergency Medicine Shock Research N. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med 2011;39(9):2066-71
   PubMed Web of Science ®Google Scholar
• Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358(2):125-39
   PubMed Web of Science ®Google Scholar
• Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358(2):111-24
   PubMed Web of Science ®Google Scholar
• Schuetz P, Litke A, Albrich WC, Mueller B. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia. Curr Opin Infect Dis 2013;26(2):159-67
   PubMed Web of Science ®Google Scholar
• Schuetz P, Briel M, Mueller B. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA 2013;309(7):717-18
   PubMed Web of Science ®Google Scholar
• Haubitz S, Mueller B, Schuetz P. Streamlining antibiotic therapy with procalcitonin protocols: consensus and controversies. Expert Rev Respir Med 2013;7(2):145-57
   PubMed Web of Science ®Google Scholar
• Younger JG, Falk JL, Rothrock SG. Relationship between arterial and peripheral venous lactate levels. Acad Emerg Med 1996;3(7):730-4
   Google Scholar
• Pro CI, Yealy DM, Kellum JA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014;370(18):1683-93
   Google Scholar
• Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36(1):296-327
   PubMed Web of Science ®Google Scholar
• Trzeciak S, Dellinger RP, Chansky ME, et al. Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med 2007;33(6):970-7
   PubMed Web of Science ®Google Scholar
• Arnold RC, Shapiro NI, Jones AE, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock 2009;32(1):35-9
   PubMed Web of Science ®Google Scholar
• Jones AE, Shapiro NI, Trzeciak S, Emergency Medicine Shock Research Network I. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 2010;303(8):739-46
   PubMed Web of Science ®Google Scholar
• Nguyen HB, Kuan WS, Batech M, Investigators A. Outcome effectiveness of the severe sepsis resuscitation bundle with addition of lactate clearance as a bundle item: a multi-national evaluation. Crit Care 2011;15(5):R229
   Google Scholar
• Jensen JU, Hein L, Lundgren B, et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 2011;39(9):2048-58
   PubMed Web of Science ®Google Scholar
• Muller B, White JC, Nylen ES, et al. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001;86(1):396-404
   PubMed Web of Science ®Google Scholar
• Linscheid P, Seboek D, Schaer DJ, et al. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 2004;32(8):1715-21
   PubMed Web of Science ®Google Scholar
• Cuquemelle E, Soulis F, Villers D, et al. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med 2011;37(5):796-800
   PubMed Web of Science ®Google Scholar
• Ingram PR, Inglis T, Moxon D, Speers D. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med 2010;36(3):528-32
   PubMed Web of Science ®Google Scholar
• Piacentini E, Sanchez B, Arauzo V, et al. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study. J Crit Care 2011;26(2):201-5
   PubMed Web of Science ®Google Scholar
• Schuetz P, Mueller B, Trampuz A. Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection 2007;35(5):352-5
   PubMed Web of Science ®Google Scholar
• Muller F, Christ-Crain M, Bregenzer T, ProHOSP Study Group. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest 2010;138(1):121-9
   PubMed Web of Science ®Google Scholar
• van Nieuwkoop C, Bonten TN, van’t Wout JW, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care 2010;14(6):R206
   PubMed Web of Science ®Google Scholar
• Schuetz P, Amin DN, Greenwald JL. Role of procalcitonin in managing adult patients with respiratory tract infections. Chest 2012;141(4):1063-73
   PubMed Web of Science ®Google Scholar
• Jones AE, Fiechtl JF, Brown MD, et al. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007;50(1):34-41
   Google Scholar
• Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011;171(15):1322-31
   PubMed Web of Science ®Google Scholar
• Schuetz P, Muller B, Christ-Crain M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2012;9:CD007498
   PubMed Web of Science ®Google Scholar
• Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009;302(10):1059-66
   PubMed Web of Science ®Google Scholar
• Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect 2011;17(Suppl 6):E1-E59
   PubMed Web of Science ®Google Scholar
• Hoeboer SH, Alberts E, van den Hul I, et al. Old and new biomarkers for predicting high and low risk microbial infection in critically ill patients with new onset fever: a case for procalcitonin. J Infect 2012;64(5):484-93
   Google Scholar
• Bunton DC, Petrie MC, Hillier C, et al. The clinical relevance of adrenomedullin: a promising profile? Pharmacol Ther 2004;103(3):179-201
   PubMed Web of Science ®Google Scholar
• Albrich WC, Dusemund F, Ruegger K, et al. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis 2011;11:112
   PubMed Web of Science ®Google Scholar
• Schuetz P, Christ-Crain M, Morgenthaler NG, et al. Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium 2007;14(6):345-51
   PubMed Web of Science ®Google Scholar
• Albrich WC, Ruegger K, Dusemund F, et al. Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial. Eur Respir J 2013;42(4):1064-75
   PubMed Web of Science ®Google Scholar
• Shapiro NI, Schuetz P, Yano K, et al. The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care 2010;14(5):R182
   PubMed Web of Science ®Google Scholar
• Schuetz P, Jones AE, Aird WC, Shapiro NI. Endothelial cell activation in emergency department patients with sepsis-related and non-sepsis-related hypotension. Shock 2011;36(2):104-8
   PubMed Web of Science ®Google Scholar
• Schuetz P, Christ-Crain M, Zimmerli W, Mueller B. Repeated measurements of endothelin-1 precursor peptides predict the outcome in community-acquired pneumonia. Intensive Care Med 2011;37(6):970-80
   Google Scholar
• Ikeda T, Ikeda K, Suda S, Ueno T. Usefulness of the endotoxin activity assay as a biomarker to assess the severity of endotoxemia in critically ill patients. Innate Immun 2014. [Epub ahead of print]
   Google Scholar
• Romaschin AD, Klein DJ, Marshall JC. Bench-to-bedside review: clinical experience with the endotoxin activity assay. Crit Care 2012;16(6):248
   PubMed Web of Science ®Google Scholar
• Shapiro NI, Trzeciak S, Hollander JE, et al. The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Ann Emerg Med 2010;56(1):52-9. e51
   PubMedGoogle Scholar
• Bagshaw SM, Bennett M, Haase M, et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med 2010;36(3):452-61
   PubMed Web of Science ®Google Scholar
• Turner KL, Moore LJ, Todd SR, et al. Identification of cardiac dysfunction in sepsis with B-type natriuretic peptide. J Am Coll Surg 2011;213(1):139-46. discussion 146-137
   Google Scholar
• Schuetz P, Haubitz S, Christ-Crain M, Pro HSG. Hyponatremia and anti-diuretic hormone in Legionnaires’ disease. BMC Infect Dis 2013;13:585
   Google Scholar
• Haubitz S, Hitz F, Graedel L, et al. Ruling out Legionella in community acquired pneumonia. Am J Med 2014. [Epub ahead of print]
   Google Scholar
• Barochia AV, Cui X, Vitberg D, et al. Bundled care for septic shock: an analysis of clinical trials. Crit Care Med 2010;38(2):668-78
   PubMed Web of Science ®Google Scholar
• Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011;364(26):2483-95
   PubMed Web of Science ®Google Scholar
• Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008;177(5):498-505
   PubMed Web of Science ®Google Scholar
• Schroeder S, Hochreiter M, Koehler T, et al. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg 2009;394(2):221-6
   PubMed Web of Science ®Google Scholar
• Hochreiter M, Kohler T, Schweiger AM, et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 2009;13(3):R83
   PubMed Web of Science ®Google Scholar
• Stolz D, Smyrnios N, Eggimann P, et al. Procalcitonin for reduced antibiotic exposure in Ventilator Associated Pneumonia - a randomized study. Eur Respir J 2009;34(6):1364-75
   PubMed Web of Science ®Google Scholar
• Bouadma L, Luyt C, Tubach F, et al. Use of Procalcitonin to Shorten ICU Patients’ Exposure to Antibiotics – The Randomized Controlled PRORATA Trial. Lancet 2010;375(9713):463-74; In press
   PubMed Web of Science ®Google Scholar